COMPARE · Data as of August 24, 2026
CTVA vs STDN
Verdict: Side-by-side breakdown using the Bull Rankings model. CTVA scored 42.8, STDN scored 44.8 — STDN leads.
Compare another set
CTVA
Corteva, Inc.
42.8
$82.81 · $55.3B
fundamentals as of
Score gap
2.0
STDN leads
STDN
Standard Nuclear, Inc.
44.8
$11.94 · $1.9B
At a glance · who leads each dimension, on the model's own rules
- Fastest growthSTDN+57.1%
- Highest qualityCTVA59 / 100
Side by side · every name on one set of axes
The model, pillar by pillar (0–100 each)
CTVA
stronger →← stronger
STDN
59
Qualityreturns · margins · balance sheet
45
42
Growthrevenue & earnings expansion
50
32
Valuevaluation vs sector peers
40
STDN is stronger on 2 of 3 pillars.
Fundamentals, head-to-head
CTVA
STDN
$629mC+
FCF
—
+3.7%C+
Rev
+57.1%A
0.19B+
D/E
—
49.6xC
P/E
—
1.31B
PEG
—
Winner per row is the stronger grade; where grades tie, the better figure breaks it. A true tie or a missing value shows no highlight.
Valuation · DCF cross-check
CTVA
STDN
241% above
Price vs fair valuelower is cheaper
—
~37%/yr
Growth the price implies10-yr FCF · lower = less priced in
—
-73%
1-yr DCF upside
—
-71%
5-yr DCF upside
—
-67%
10-yr DCF upside
—
The DCF is a cross-check on intrinsic value, separate from the quality-growth score above.
Model signals
CTVA
Why this score
- Raising its dividend
- Short track record
STDN
Why this score
- Cyclical growth
- Short track record
The companies
CTVACorteva, Inc.
Why now
Agricultural Inputs · market cap $55.3b. 9% off the 52-week high of $90.97. 20 sell-side analysts rate this a Buy with a mean 1-yr target of $92.10 (implying +11% upside).
Moat
$55.3b market cap gives the company enough scale to absorb fixed costs that subscale competitors can't, without yet being so large that growth has to come from acquisition.
Risk
Trailing P/E 50x sits well above the S&P median (~20x) — multiple compression is a real risk if revenue growth decelerates. ROE 4% is below the long-run sustainable threshold of ~10% — capital efficiency would need to improve for the equity base to compound at the market rate.
STDNStandard Nuclear, Inc.
Why now
Specialty Chemicals · market cap $1.9b. 15% off the 52-week high of $13.98. Revenue growing +57% — in hypergrowth territory. 8 sell-side analysts rate this a Strong Buy with a mean 1-yr target of $16.00 (implying +34% upside).
Moat
Higher-variance name — the moat signals on the quantitative card are modest, so the durability case rests on execution (turning current growth into durable earnings power) or an un-monetized asset (IP / network effects / first-mover position) rather than an entrenched competitive position.
Risk
Higher-variance name — the thesis leans on growth and valuation rather than a long, settled track record, so it depends on execution continuing. Position size accordingly; a deep drawdown shouldn't change the thesis.
Verdict — model-derived comparison
Generating verdict… typically 5–10 seconds
Not investment advice. The Bull Rankings publishes a quantitative ranking model and accompanying analysis for general informational purposes only. Nothing on this page is a recommendation to buy, sell, or hold any security; nothing is personalized to your circumstances, risk tolerance, or tax situation. Investing carries the risk of loss — invest at your own risk and consider consulting a licensed financial professional before acting on anything you read here. See terms and methodology for full disclosures.
Where CTVA and STDN diverge
On the headline score the gap is 2.0 points in favor of STDN. They get there differently, though — each leads on a different pillar, so the better pick depends on which you weight.
- QualityCTVA 59.3 · STDN 45.0CTVA +14.3
- GrowthCTVA 41.7 · STDN 50.0STDN +8.3
- ValueCTVA 31.7 · STDN 40.0STDN +8.3
Pillars run 0–100 against sector peers, so a score is a statement about a company relative to its own industry rather than to the other name here. A wide Value gap usually means the market already prices the difference in quality or growth — which is the trade-off this comparison comes down to.